FDA Safety and Innovation Act
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:amendedBy |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
| gptkbp:containsProvision |
reauthorization of Generic Drug User Fee Amendments
reauthorization of Medical Device User Fee Amendments reauthorization of Biosimilar User Fee Act reauthorization of Prescription Drug User Fee Act |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:dateEnacted |
2012-07-09
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:goal |
improve safety and innovation in medical products
|
| https://www.w3.org/2000/01/rdf-schema#label |
FDA Safety and Innovation Act
|
| gptkbp:publicLawNumber |
gptkb:Public_Law_112-144
|
| gptkbp:shortName |
gptkb:FDASIA
|
| gptkbp:signedBy |
gptkb:Barack_Obama
|
| gptkbp:subject |
gptkb:Food_and_Drug_Administration
medical device user fees drug regulation |
| gptkbp:bfsParent |
gptkb:Medical_Device_User_Fee_Amendments
|
| gptkbp:bfsLayer |
7
|